If you're on a weight loss journey, you might have started incorporating more movement into your day
[7] In a Bayesian network meta-analysis of 48 randomized trials and nearly 28,000 participants, the dominant gastrointestinal events were nausea (about 21.5%), diarrhea (10.6%), vomiting (9.1%), and constipation (7.9%), with semaglutide carrying one of the highest constipation risks
Many patients stay on the medication for several months or even longer, depending on their weight loss goals and how their body responds
Researchers using the semaglutide dosage calculator at SeekPeptides can determine exact unit measurements based on their vial concentration and target dose
And studies are emerging
Ozempic is a GLP-1 receptor agonist, meaning it mimics the GLP-1 hormone that is naturally produced in the intestines